Picture of Carl Zeiss Meditec AG logo

AFX — Carl Zeiss Meditec AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Carl Zeiss Meditec FY 2022/23 Revenue Up By Around 10%

Dec 12 (Reuters) - CARL ZEISS MEDITEC AG  AFXG.DE :
    * INCREASED REVENUE IN FISCAL YEAR 2022/23 BY AROUND 10
PERCENT
    * COMPANY CONSIDERS OUTLOOK FOR FISCAL YEAR 2023/24 TO BE
LARGELY
POSITIVE, AS UNDERLYING LONG-TERM DEVELOPMENT TRENDS CONTINUE TO
PERSIST
    * EBIT IS EXPECTED BE AT ROUGHLY SAME LEVEL AS IN PRIOR YEAR
IN
FISCAL YEAR 2023/24
    * REVENUE GROWTH FOR FISCAL YEAR 2023/24 AS A WHOLE IS
EXPECTED TO
BE AT LEAST AS HIGH AS MARKET GROWTH
    * EBIT AND EBIT MARGIN SHOULD BE HIGHER AGAIN IN SECOND HALF
OF
2023/24 THAN IN SECOND HALF OF 2022/23
    * IN MEDIUM TERM, COMPANY EXPECTS TO BE ABLE TO STABILIZE
ITS EBIT
MARGIN SUSTAINABLY ABOVE 20%
    * MANAGEMENT BOARD AND SUPERVISORY BOARD PLAN TO PROPOSE A
DIVIDEND OF EUR 1.10 TO ANNUAL GENERAL MEETING, UNCHANGED FROM
PRIOR YEAR

Source text for Eikon:  ID:nEQ9bxH9Pa 
Further company coverage:  AFXG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Carl Zeiss Meditec AG

See all news